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Ultraviolet-B-induced erythema (one, two, or four
times the minimal erythema dose) was reduced but
not abolished by application of 1% indomethacin gel
immediately after irradiation of human skin.
Continuous synthesis of prostaglandins is re¯ected by
similar levels of indomethacin-mediated inhibition of
erythema at any time within 48 h after irradiation.
Repeated applications of indomethacin did not
increase the inhibition. Twenty-four hours after
irradiation with four minimal erythema doses, mean
prostaglandin E2 levels in suction blisters were
27.2 ng per ml (SEM 11) compared with 8.6 ng per
ml in unirradiated skin (n = 25; p < 0.01). Prosta-
glandin E2 levels in dermal tissues, sampled by micro-
dialysis (depth 0.6 6 0.1 mm), were 310 pg per ml
(SEM 123) and 237 pg per ml (SEM 88) in irradiated
and unirradiated skin, respectively (n = 7, n.s.). Nitric
oxide also made a signi®cant contribution to ultravio-
let-B-induced erythema. Ultraviolet erythema was
inhibited by L-NAME in a dose-related fashion with
2 mM L-NAME causing total abolition of the
response. L-NAME was effective at all time points up
to 48 h suggesting that NO was produced continu-
ously. NO was undetectable in suction blister ¯uid
but in dermal microdialysate NO was present at
44.3 ng per ml (SEM 6.2) following ultraviolet B
compared with 26.0 ng per ml (SEM 8.0) in unirra-
diated skin (p < 0.05), approximately 1000 times the
molar concentration of prostaglandin E2. These ®nd-
ings con®rm prostaglandin E2 and NO to be medi-
ators of ultraviolet-induced erythema. They also
show that there is prolonged synthesis of both medi-
ators within the erythemal response and that synthesis
of NO is induced by lower doses of ultraviolet B com-
pared with that of prostaglandin E2. Key words:
indomethacin/L-NAME/microdialysis/nitric oxide/prosta-
glandin E2. J Invest Dermatol 117:880±885, 2001
E
xposure of human skin to ultraviolet B (UVB) radiation
results in a complex response comprising vasodilatation
with subsequent in®ltration of neutrophil leukocytes
(Strickland et al, 1997), activation of melanogenesis, and
epidermal cell proliferation. UVB induces the release of
many mediators including prostaglandins (PG) (Black et al, 1978a;
1980), nitric oxide (NO) (Warren et al, 1993; Goldsmith et al,
1996), and the cytokines tumor necrosis factor a (TNF-a)
(Oxholm et al, 1988; Kock et al, 1990), interleukin-1 (IL-1)
(Kupper et al, 1987), IL-6 (Oxholm, 1992), IL-8 (Kondo et al,
1993; Strickland et al, 1997) and IL-10 (Enk et al, 1995).
Elucidation of the roles of individual mediators and the mechanisms
underlying the different components of the response would give
important understanding of many aspects of cutaneous biology.
The vasodilatation is among the earliest parts of the response;
erythema ®rst becomes detectable 3±4 h after exposure, is maximal
between 8 and 24 h, and persists for more than 48 h (Andersen et al,
1991). The prolonged nature of UVB-induced vasodilatation
suggests either involvement of mediators with a very long duration
of action, or the continued synthesis of mediator(s) throughout the
response. Alternatively, different mediators may modulate the early
and later phases of the response. It is well known that PG are
involved in UVB-induced erythema as the vasodilatation is reduced
by indomethacin, an inhibitor of cyclo-oxygenase (COX), given
orally (Greenberg et al, 1975; Black et al, 1978b), by intradermal
injection (Snyder and Eaglstein, 1974a), or by topical application
(Snyder and Eaglstein, 1974a; Farr and Diffey, 1986). Also, PGE2
has been found in suction blister ¯uid taken from sites of UVB-
induced erythema (Black et al, 1980; Rhodes et al, 1995). Similarly,
NO has been implicated in UVB-induced vasodilatation as
inhibition of NO synthase (NOS) with L-NMMA reduced the
erythema (Warren, 1994), although NO has not been measured
directly in UV-irradiated skin. Little is known, however, about the
time course of the activation of COX and NOS which leads to the
generation of PG and NO, nor the site within the skin where the
mediators are synthesized. The sharp edges to UV-induced
erythema have led to speculation that there is little diffusion of
mediators away from the exposed area, nor activation of other
vasodilator pathways involving a neurogenic re¯ex or other
secondary mediator release. The aims of this study were, ®rst, to
examine the time course of activation of COX and NOS by use of
pharmacologic blockade of their activities. Second, we aimed to
quantify the production of PGE2 and NO in different compart-
ments of the skin by sampling the epidermis with suction blisters
and the super®cial dermis with microdialysis. In this way we hoped
to establish the relative contributions of these two mediators to
both the generation and maintenance of UVB-induced erythema.
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MATERIALS AND METHODS
Adult Caucasian subjects were studied during the winter or spring
months. The study group consisted of normal volunteers and patients
with nonin¯ammatory skin disorders and no history of photosensitiv-
ity. None of the subjects had been treated with psoralen plus UVA
or with UVB in the previous 6 mo or had used a commercial
sunbed or acquired a suntan during this time. Local ethics committee
approval was obtained, all volunteers gave written informed consent,
and the study conformed to the Declaration of Helsinki.
UV irradiation The UV irradiation source used was a ¯uorescent
UVB lamp, Philips TL20W/12 (emission spectrum 270±400 nm, peak
310 nm). The lamp was mounted in slightly different luminaires for
the studies of effects of inhibition of PG and NO oxide synthesis.
For studies of PG inhibition, the lamp was housed in a black plastic
tube with ®ve apertures of 1 cm in the side. Four of the apertures
were covered by neutral density ®lters, giving relative irradiances at
the ®ve apertures of 1.0, 0.75, 0.61, 0.51, and 0.35. A geometric
series of 10 doses ranging from 7 to 80 mJ per cm2 of erythemally
weighted UV radiation was given in a horizontal row across the
lower back, by applying the lamp directly to the skin (Diffey and
Oliver, 1985). For studies of NO inhibition, the luminaire had eight
apertures, seven covered by neutral density ®lters giving relative
irradiances of 1.0, 0.79, 0.63, 0.5, 0.4, 0.32, 0.25, and 0.2.
Irradiance was measured with an IL1400A radiometer (International
Light). The irradiated sites were assessed visually at 24 h, and the
minimal erythema dose (MED), i.e., the lowest UV dose that
produced a perceptible erythema, was noted. Erythema was also
quanti®ed using a re¯ectance instrument, as described below.
Assessment of erythema Erythemal responses in our studies were
assessed with the use of a re¯ectance instrument and/or a laser
Doppler ¯owmeter. The re¯ectance instrument (Diastron, U.K.) gives
an erythema index related to the blood content of the super®cial
dermis. Triplicate measurements were taken at each test site, and the
results were expressed as the difference between the mean erythema
index at each test site and that of adjacent unirradiated skin. The
laser Doppler ¯owmeter (MBF3, Moor Instruments, Axminster, U.K.)
measured red cell ¯ux over 1 min, and the data are presented as
percentage ¯ux of unirradiated skin.
Effects of an inhibitor of COX (indomethacin) on UVB-induced
erythema
UVB dose±response To investigate whether blockade of PG synthesis
had different effects at different UVB doses, a geometric series of
erythemally weighted UV radiation (7±80 mJ per cm2) was given in
duplicate horizontal rows to each side of the lower back (n = 18).
The sites were circular and 1 cm in diameter. Indomethacin gel (1%)
was applied at a surface density of 100 mg per cm2 to sites on one
side of the back, under plastic ®lm occlusion, for 3 h. A surface
density of 100 mg per cm2 indomethacin was chosen as this has
previously been shown to produce maximal suppression of UVB
erythema (Farr and Diffey, 1986). The gel base has previously been
shown to have no effect on UV erythema (Farr and Diffey, 1986).
The sites were examined at 24 h and the MED was noted.
Erythemal readings were taken with the re¯ectance instrument and
dose±response curves were constructed; the slope of the central linear
portion was calculated.
Erythemal time course To see whether initial inhibition of PG synthesis
had different effects on the time course of erythema induced by different
doses of UVB, 12 subjects received three doses of UVB: 1 3 MED, 2
3 MED, and 4 3 MED, to each side of the lower back. Immediately
following irradiation, a measured volume of indomethacin gel, giving a
surface concentration of 100 mg per cm2, was applied for 2 h under
plastic ®lm occlusion to sites on one side of the back. To see whether
repeated applications of indomethacin could produce greater inhibition
of UVB-induced erythema, three further applications of indomethacin
were made to these sites at 12, 24, and 36 h, in six subjects.
Indomethacin could not be applied more frequently due to its irritant
effect.
As precise de®nition of the early part of the response was desired, the
®rst group of six subjects (single indomethacin application) were exam-
ined three hourly to 12 h, and then at 24 h and 48 h. The second group
of six (repeated indomethacin applications) were assessed at 12, 24, 36,
and 48 h. The sites were assessed visually and objective measurements
were made with the re¯ectance instrument. Dose±response curves were
constructed.
Effects of a NOS inhibitor (L-NAME) on UVB-induced
vasodilatation
Dose±response of L-NAME Five sites on the volar forearm were
irradiated with 2 3 MED of UVB. Twenty-four hours later four of
the irradiated sites received 50 ml of one of four doses of L-NAME
(0.02, 0.2, 1, and 2 mM) dissolved in phosphate-buffered saline
(PBS); the ®fth site received 50 ml of PBS. Each substance was
injected as super®cially as possible into the dermis to raise a bleb at
the center of a marked circle. Readings of blood ¯ux were made
with the laser Doppler ¯owmeter 30 min after injection at which
time the effect has been shown to be maximal (data not shown).
Triplicate readings were taken at each site and the means, expressed
as a percent of the value in adjacent unirradiated skin, were plotted
as a dose±response curve.
UVB dose±response A geometric series of eight doses of erythemally
weighted UV radiation (14±80 mJ per cm2) was given in duplicate
to the volar forearm of eight subjects as described above. The sites
were examined at 24 h and the MED was noted. Sites showing
visible erythema were injected ± one series received 50 ml of L-
NAME (0.5 mM), and the other series received 50 ml of PBS.
Thirty minutes later, three sets of recordings of 15 s each were
made at the test sites and at two unirradiated control sites and the
means were noted; results were presented as percentage ¯ux of
unirradiated skin. The data were normalized to the MED (designated
as dose 1) for each volunteer and the subsequent normalized doses
were designated doses 2, 3, etc. Dose±response curves were
constructed and the slope of the central linear portion was analyzed.
Erythemal time course Three areas 3 3 10 cm on the volar surface of
the forearm were irradiated with 2 3 MED 6 h, 24 h, and 48 h
prior to intradermal injection of L-NAME. The 24 h site was
injected with 50 ml L-NAME at concentrations of 0.02, 0.2, 1, and
2 mM in PBS in order to elicit the dose±response. L-NAME
(1 mM) was injected into the 6 h and 48 h sites. All UV-exposed
sites received control injections of 1 mM D-NAME and also PBS.
Three recordings of blood ¯ux, lasting 15 s each, were made at each
test site and at four unirradiated control sites, and the means were
noted. Data are presented as percentage ¯ux of unirradiated skin.
MEASUREMENT OF MEDIATORS
Sampling methods
Suction blister method Areas of skin on the volar forearm were
irradiated with 4 3 MED (having determined MED previ-
ously). Twenty-four hours later, suction blister cups (Ventipress
Oy, Finland) were applied with a vacuum of 250 mmHg
according to our previous method (Rhodes et al, 1995). When
blisters had formed (after about 90 min), the ¯uid was aspirated
with a 23 gauge needle and immediately frozen at ±80°C for
subsequent assay of PGE2 and NO. Blister ¯uid PGE2 was
measured by radioimmunoassay, using a commercial kit
(Amersham Pharmacia Biotech). NO, present as nitrite
(NO2
±) (Clough, 1999), was assayed in 10 ml samples of blister
¯uid using a chemiluminescence method (Sievers NOA 280,
Sievers, Boulder, CO). The system was calibrated using known
concentrations of NaNO2 and was sensitive to 2 pmol.
Dermal microdialysis An area 3 cm square on the volar
forearm was exposed to 4 3 MED of UVB (having determined
MED previously). Twenty-four hours later, the irradiated site
and an unirradiated control site nearby were anesthetized with
topically applied EMLA (lignocaine/prilocaine mixture, Astra,
Kings Langley, U.K.), under plastic ®lm occlusion for 2 h.
Microdialysis ®bers (two per site) with a molecular mass cut-off
of 5 kDa were inserted parallel to the skin surface at a depth of
0.6 6 0.1 mm (measured with 20 MHz ultrasound, Dermascan;
C. Cortex Technology, Handsund, Denmark). The intradermal
®ber length was 2 cm. After a 2 h recovery period, the ®bers
were perfused with PBS at a rate of 5 ml per min and the
dialysate was collected over 30 min. The samples were snap
frozen and stored at ±80°C until analysis. PGE2 was measured
in 50 ml aliquots by enzyme-linked immunosorbent assay
(Amersham Pharmacia Biotech); NO was measured in 10 ml
samples of dialysate using a chemiluminescence assay (see
above).
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Statistical analysis Parameters of erythemal sensitivity were
examined by a general linear model analysis of variance, using the
SAS statistical package (SAS Institute, Cary, NC). Paired data were
compared using Student's t test or Wilcoxon's signed ranks test, and
unpaired data were analyzed using the Mann±Whitney U test.
Statistical signi®cance was accepted at the p < 0.05 level.
RESULTS
Indomethacin reduces the slope of the erythemal dose±
response to UVB As the UVB dose was increased from 1 to 4 3
MED, so the effect of blockade of PG synthesis with indomethacin
increased progressively. A typical response to UVB alone and UVB
+ indomethacin in an individual is shown in Fig 1(a). The mean
slopes of the linear portion of the response to UVB alone and UVB
+ indomethacin were 0.232 (SD 0.01) and 0.147 (SD 0.01),
respectively, n = 18 (p < 0.01; Fig 1b).
A single application of indomethacin reduces UVB-induced
erythema for up to 24 h When indomethacin was applied
immediately after UV irradiation the effect varied depending on the
dose of UVB (Fig 2). At 1 3 MED, indomethacin appeared to
have little or no effect on the intensity of the erythema detected by
eye or with the erythema meter. At 2 3 MED and 4 3 MED,
however, the initial erythema was much less intense at the
indomethacin-treated sites: the 2 3 MED sites were suppressed up
to 12 h and the 4 3 MED sites to 24 h (p < 0.05). By 36±48 h, the
effect of the indomethacin had worn off and no difference could be
seen between the treated sites and the control sites (Fig 2).
Repeated applications of indomethacin suppress UVB-
induced erythema up to 48 h At the 1 3 MED site, there
was little difference between the treated and untreated sites (Fig 3).
Evidence of suppression of the erythemal response, however, was
seen to 36 h at the 2 3 MED sites and to 48 h at the 4 3 MED sites
(p = 0.06). It was notable that, even following repeated
applications, indomethacin could not completely suppress the
erythemal response, i.e., there was an ``irreducible'' minimum.
L-NAME produces a dose-dependent inhibition of UVB-
induced vasodilatation Four doses of L-NAME (0.02±2 mM)
were injected into sites irradiated 24 h previously with 2 3 MED of
UVB and vascular responses were observed at 30 min. A clear
dose-dependent reduction in blood ¯ux was observed following
injection of L-NAME, with a fall to the level of baseline
unirradiated skin in all six subjects at the 2 mM concentration (p
< 0.01) (Fig 4).
L-NAME inhibits the vasodilatation dose±response to UVB
irradiation The effect of L-NAME on the UVB erythemal
dose±response was assessed in eight individuals (Fig 5a, b). There
was strong inhibition of the vasodilatation response at all UV doses
and the maximum amplitude of response to UVB irradiation also
Figure 2. The effects of a single application of 1% indomethacin gel or control gel base on the time course of erythema induced by
UVB (1 3 MED, 2 3 MED, and 4 3 MED). N = 6. Solid symbols are from sites treated with gel base; open symbols are from sites treated with
indomethacin gel. Points are means, error bars are SEM.
Figure 1. Indomethacin reduces the slope of UVB-induced
erythemal papilla. (a) A representative example. Results are means 6
SEM of triplicate readings. Solid symbols are responses from control sites
treated with gel base, and open symbols are from sites that received 1%
indomethacin gel immediately after irradiation. (b) The slopes of the
linear portions of the UVB-induced erythema dose±response curves from
18 individuals: (i) the curve from the responses treated with gel base; (ii)
the curve from the responses treated with 1% indomethacin. The dotted
lines show the 95% con®dence intervals for the slopes.
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appeared to be reduced (Fig 5a). The slopes of the linear portions
of the dose±response curves after injection of PBS or L-NAME
were similar: 248.4 (SD 6 94.3) and 280.6 (6 83) units,
respectively. These are plotted in Fig 5(b) and show that L-
NAME causes a parallel shift to the right (p < 0.005, ANOVA).
L-NAME reduces UVB-induced vasodilatation at 6, 24, and
48 h To see whether NO was produced throughout the course
of UVB-induced vasodilatation, the effect of L-NAME on
erythema-related blood ¯ow was observed at 6, 24, and 48 h
following irradiation. A marked reduction in blood ¯ux occurred
following injection of 1 mM L-NAME at all three sites. Compared
with preinjection readings, the ¯ux fell by 79.8% at 6 h
postirradiation (p < 0.05), by 83.5% at the 24 h site (p < 0.05),
and by 82.9% at 48 h postirradiation (p < 0.05). The control
substances, D-NAME and PBS, produced a slight increase in ¯ux
following injection, with no visible blanche effect (Table I).
PGE2 and NO levels in epidermal suction blisters and
dermal microdialysates PGE2 levels in suction blister ¯uid rose
from 8.6 (SEM 2.1) ng per ml in unirradiated control sites to 27.2
(SEM 11) ng per ml in UV-exposed sites (p < 0.01, n = 22). The
concentration of PGE2 in dermal microdialysate collected over
30 min was 0.24 ng per ml (SEM 0.09) before UVB exposure and
0.31 ng per ml (SEM 0.12) after irradiation (n.s.). Whereas NO was
not detectable in suction blister ¯uid (n = 5), the concentration of
NO in dermal microdialysate in unirradiated skin was 3.9 ng per ml
(SEM 1.2), increasing to 6.64 ng per ml (SEM 0.93) 24 h after
irradiation with 4 3 MED (p < 0.05, n = 7, paired t test).
DISCUSSION
The results presented here provide con®rmatory evidence for the
involvement of both PGE2 and NO in the production of UVB-
induced erythema. They show that there is sustained production of
both mediators throughout at least 48 h following exposure to
UVB. The observation that the erythema induced by low doses of
UVB (1 3 MED) was not inhibitable by indomethacin but was
completely abolished by L-NAME suggests that NO is induced by
lower doses of UVB than PGE2.
Figure 3. The effects of 12 hourly repeated applications of 1% indomethacin gel or control gel base on the time course of erythema
induced by UVB (1 3 MED, 2 3 MED, and 4 3 MED). N = 6. Solid symbols are from sites treated with gel base; open symbols are from sites
treated with indomethacin gel. Points are means, error bars are SEM.
Figure 4. The dose±response effects of L-NAME on UVB-
induced vasodilatation. An area of volar forearm received 2 3 MED
of UVB 24 h previously. L-NAME was injected in 50 ml volumes at the
concentrations shown. Laser Doppler readings of the blood ¯ux were
taken 30 min after injection. The means and SEM of triplicate readings
of blood ¯ux at each site are expressed as percent of that in unirradiated
adjacent control skin, shown by dashed line. N = 6.
Table I. L-NAME inhibits erythemal response to UVB at 6, 24, and 48 ha
6 h UVB
L-NAME
24 h UVB
L-NAME
48 h UVB
L-NAME
48 h UVB
D-NAME
48 h UVB
PBS
Uninjected control site 228b (15) 255 (90) 205 (55) 205 (55) 228 (70)
Injected site 48* (22) 42* (15) 35* (5) 215 (25) 250 (25)
79%c 83.5% 82.9% ±5% ±10%
aAn area 3 3 10 cm was irradiated with 2 3 MED; L-NAME (1 mM) or D-NAME or PBS were injected at the times shown and the blood ¯ow was measured with
the laser Doppler meter.
bMean arbitrary blood ¯ux units (SEM), n = 6.
c% reduction of ``agonist''-injected site compared with uninjected site.
*p < 0.05 compared with uninjected control site (paired t test).
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Application of indomethacin resulted in pronounced inhibition
of UVB-induced erythemal responses, with both reduction in
magnitude and delay in erythema development. These results
con®rm the ®ndings of several previous studies, which suggested an
important role for PG in UVB-induced erythema. The duration of
indomethacin-mediated suppression was UV dose-dependent, as
previously reported by others (Andersen et al, 1991). Thus, a single
application of indomethacin had a minimal effect at 1 3 MED; at 2
3 MED erythema was suppressed for 12 h but by 48 h had caught
up to levels recorded in control sites not given indomethacin,
whereas erythema at sites given 4 3 MED was suppressed to 24 h
before increasing to levels seen in control sites that received no
indomethacin. Consistent with other reports (Farr and Diffey,
1986), indomethacin applied immediately after irradiation to a full
range of UVB doses produced a signi®cant reduction in slope of the
dose±response curve. At minimal erythema doses, the weaker
erythema was not suppressed at all by indomethacin. Hence, it
appears that as UVB dose is increased, so PG plays a progressively
more prominent role in the vasodilatation.
The data presented suggest that PG are important both early on
and also between 24 and 48 h in the maintenance of UVB
erythema. Farr and Diffey (1986) showed that a single application
of indomethacin gel at various time points during the ®rst 24 h
following UVB irradiation resulted in suppression of UV erythema,
with full recovery at 48 h. They reported, however, that a single
application after 24 h had no effect. In this study repeated
application of indomethacin resulted in suppression of erythema at
48 h, suggesting more complete suppression of PG synthesis.
Moreover, this indicates continuous synthesis of PG through
sustained activation of COX enzymes. An interesting alternative
interpretation of these ®ndings is that the repeated indomethacin
applications led to such a prolonged inhibition during the ®rst 24 h
of the response that other mediators normally involved in the
maintainance of the response over the subsequent 24 h are not
generated. It is possible that their synthesis is dependent on
maintained increases in blood ¯ux or on earlier prostanoid
synthesis.
The UVB-induced erythema was only partially suppressed by
topical indomethacin, and other investigators have reported
incomplete suppression following indomethacin given orally
(Greenberg et al, 1975), by intradermal injection (Snyder and
Eaglstein, 1974a), or applied topically (Snyder and Eaglstein,
1974b; Farr and Diffey, 1986). Interestingly, Black et al (1978b)
found that oral indomethacin only partially inhibited the erythema,
but completely suppressed the increase in PG in suction blister
¯uid, at 24 h after UVB irradiation. Hence, whereas COX products
appear to play an important part in UVB erythema, other mediators
are likely to be involved. Therefore, we examined the involvement
of NO, a mediator that might contribute to the ``indomethacin
unresponsive'' component of the early and late phases of the UVB
erythemal response.
In contrast to indomethacin, L-NAME abolished erythema at
lower UVB doses but could not abolish it at higher UVB levels
(Fig 5a). Although a dose-related effect cannot be ruled out, this
indicates that the NO component of vasodilatation operates at low
UVB erythema, but that a second mediator contributes at higher
UVB doses. It has been suggested that NO may also activate COX
(Salvemini et al, 1993) leading to increased PG production, and
hence a link between the COX and NOS pathways could be
important in the in¯ammatory response. There was evidence of
continuous synthesis of NO and hence sustained activation of NOS
± presumable iNOS. Warren showed that the combination of
indomethacin and L-NAME could abolish higher levels of UV
erythema (Warren, 1994). Again, in contrast to the results obtained
with indomethacin, L-NAME injected into a UVB dose series
resulted in a parallel shift to the right of the vasodilatation dose±
response curve (Fig 5b). This is similar to the effect of a
``competitive inhibitor'' on a pure pharmacologic or receptor-
mediated response, and might indicate that release of NO is the key
pharmacologic initiator of the UVB-induced vasodilatation re-
sponse.
The reduction of vasodilatation following L-NAME was seen at
6, 24, and 48 h postirradiation, and was temporary, thus agreeing
with a recent report (Goldsmith et al, 1996) and giving evidence for
the continuous synthesis of NO throughout the course of UVB-
induced vasodilatation. The above ®ndings suggest that the
production of NO by the endothelium could provide an effective
Figure 5. L-NAME inhibits UVB-induced vasodilatation, but does
not change the slope of the dose-response curve. (a) Duplicate
series of UVB were given to the volar forearms of eight volunteers. The
MED was noted and sites showing visible erythema were injected ± one
series received 50 ml of L-NAME (0.5 mM), and the other series
received 50 ml of PBS. Thirty minutes later, blood ¯ux was measured
with a laser Doppler blood ¯owmeter. Values were expressed as percent
of that in unirradiated control skin, and means and SEM were plotted.
Solid symbols and line are from PBS-injected sites, and open symbols and
line are from L-NAME-injected sites. The data were normalized by
calling the MED dose 1, and higher doses were dose 2, 3, etc. (b) The
regression of the linear portions of each curve (between doses 4 and 6)
were plotted. The dashed curved lines are the 95% con®dence intervals for
the slopes.
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route for the production and maintenance of the erythemal
response to UVB irradiation.
The data from the suction blisters and dermal microdialysate give
information suggestive of the differing balance in mediator synthesis
at different sites following UVB irradiation. In view of the different
methodologies and the possibility that protein contamination of
suction blister ¯uid may result in a reduction in the detectable NO,
however, it is not possible to draw any ®rm conclusions on this
point.
In conclusion, our results clarify the roles of NO and PGE2 in
the generation of UVB-induced vasodilatation, indicating that NO
is induced by low doses of UVB (< 1 MED). Above this, PG start
to make a contribution, which is related to the UVB dosage. It
remains to be shown whether PGE2 is generated as a consequence
of activation of COX by NO.
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